Brontec PLUS – Interbio – 500ml
Clenbuterol + Bromhexine
Maximum efficacy against respiratory diseases.
Mucolytic, decreases the viscosity of the mucus.
Secretolytic, it increases the speed of elimination of the bronchial mucus.
Expectorant, increases bronchial secretions to the outside.
Strengthens the body’s defenses by increasing the level of gamma globulins.
Increases the concentration of antibiotics in pulmonary secretion 2 to 3 times when administered simultaneously.
Antitussive, calms irritating coughs.
The product is a combination of a bronchodilator and a mucolytic and expectorant, indicated for respiratory diseases in equines.
Clenbuterol 0.04 mg
Bromhexine 1.25 g
For the treatment of respiratory infections and bronchial obstructions that occur with accumulation of mucus and / or bronchospasm with acute and chronic conditions in horses: Cough and dyspnea due to bronchial spasm, COPD, Bronchitis, Bronchopneumonia.
Brontec Plus also stimulates mucociliary cleansing.
Combined treatment with antibiotics and / or sulfonamides is indicated in acute cases of bronchitis and bronchopneumonia.
Brontec Plus Clenbuterol has the following actions:
Bronchodilator action: it acts at the level of the beta receptors of the bronchial muscles, solving reversible bronchospasm, increasing air passage and normalizing respiration.
Expectorant action: Increases secretomotor activity (ciliary movement), by increasing cellular energy metabolism promoting the elimination of mucus.
Anti-allergic action: prevents the release of histamine by stabilizing the cell membrane of mast cells.
Anti-inflammatory action: Inhibits the formation of inflammatory mediators (Prostaglandins and Leukotrins), helping to control inflammatory symptoms.
Bromhexine from Brontec Plus: Produces a depolymerization of mucopolysaccharides, reducing the viscosity and toughness of respiratory mucus. This facilitates expectoration and suppresses an irritating cough. The increased production of viscous bronchial and alveolar secretions is not only a clinical sign of respiratory disease, but an exacerbating factor of it. Disordered ciliary function and difficult expectoration create a vicious cycle in which mucosal tenacity leads to chronic bronchitis. Bromhexine is a specific agent to prevent this complication. It has a minimal secretolytic effect when mucosal viscosity is initially low. Increases the permeability of the alveolar-capillary barrier. This increases the concentration of antimicrobial agents in respiratory secretions, obtaining a greater effect of the dose at the level of the injury site. It causes changes in the specific proteins of the bronchial secretion. After 2 to 3 days of treatment there is a significant increase in gamma globulins and a decline in albumins and alpha globulins. The increased gamma globulins are IgA and IgG, while IgM remains unchanged.
Dosage and Administration:
Orally administer 2 ml of the gel every 100 kg b.w. twice daily.
After an obvious improvement, the volume of the feedings or the number of daily feedings can be reduced. The duration of treatment depends on a considerable number of factors related to the disease, etiology, duration of the process, etc. that the treating Veterinarian will evaluate appropriately.
In acute and subacute cases, treatment will continue for 10 to 14 days. In chronic processes, it will be treated for at least 4 weeks until the total absence of symptoms is reached. In patients who are hypersensitive to environmental allergens, treatment can be administered discontinuously.